FSD Pharma to Present at the KCSA Psychedelics Virtual Investor Conference on October 13th

About this update from Quantum Biopharma Ltd. Subordinate Voting Shares Class B

[{"type":"text","content":"\n \n \n \n FSD Pharma to Present at the KCSA Psychedelics Virtual Investor Conference on October 13th\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n PR Newswire\n \n \n \n \n \n TORONTO\n \n ,\n \n Oct. 13, 2021\n \n /PRNewswire/ -- FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (\"\n \n FSD Pharma\n \n \" or the \"\n \n Company\n \n \"), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, is pleased to announce that\n \n Anthony Durkacz\n \n , Interim CEO of FSD Pharma, and Dr. Lakshmi P. Kotra, CEO of FSD's wholly-owned subsidiary Lucid Psycheceuticals, will participate in the KCSA Psychedelics Investor Conference to be held at\n \n \n VirtualInvestorConferences.com\n \n \n on\n \n October 13-14, 2021\n \n .\n \n \n \n \n \n \n \n \n \n Mr. Durkacz and Dr. Kotra will present live on\n \n Wednesday, October 13\n \n \n th\n \n at\n \n 2:30 p.m. ET\n \n . Register to attend\n \n \n here\n \n \n .\n \n \n For more information about the conference, or to schedule a one-on-one meeting with FSD's management team, please contact KCSA Strategic Communications at\n \n \n [email protected]\n \n \n .\n \n \n \n About Virtual Investor Conferences®\n \n \n Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.\n \n \n A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group's suite of investor relations services specifically designed for more efficient Investor Access.  Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.\n \n \n Learn more about VIC and its events at\n \n \n www.virtualinvestorconferences.com\n \n .\n \n \n \n \n About FSD Pharma\n \n \n FSD Pharma is a life sciences holding company dedicated to building a portfolio of d...

More updates from Quantum Biopharma Ltd. Subordinate Voting Shares Class B